Comparison Intensity Therapeutics (INTS) with Competitors
Intensity Therapeutics (INTS) industry is Biotechnology.
Free Cash Flow Yield
INTS-73.76%
Industry-1.75%
Upside-72.02%
P/E
INTS-0.81
Industry-20.52
Upside+1970.40%
P/B
INTS1.32
Industry5.15
Upside-74.37%